P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970916.77031.e7 |
| _version_ | 1797280075849138176 |
|---|---|
| author | Ciro Rinaldi Kristian Boasman Matthew Simmonds |
| author_facet | Ciro Rinaldi Kristian Boasman Matthew Simmonds |
| author_sort | Ciro Rinaldi |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:35:03Z |
| format | Article |
| id | doaj.art-012e5283c4cd49728b6cdc77d40c36cc |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:35:03Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-012e5283c4cd49728b6cdc77d40c36cc2024-03-03T09:43:38ZengWileyHemaSphere2572-92412023-08-017e77031e710.1097/01.HS9.0000970916.77031.e7202308003-00903P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY.Ciro Rinaldi0Kristian Boasman1Matthew Simmonds21 University of Lincoln, Pool, United Kingdom1 University of Lincoln, Pool, United Kingdom1 University of Lincoln, Pool, United Kingdomhttp://journals.lww.com/10.1097/01.HS9.0000970916.77031.e7 |
| spellingShingle | Ciro Rinaldi Kristian Boasman Matthew Simmonds P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY. HemaSphere |
| title | P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY. |
| title_full | P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY. |
| title_fullStr | P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY. |
| title_full_unstemmed | P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY. |
| title_short | P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY. |
| title_sort | p1003 ruxolitinib and magrolimab increases calreticulin in myelofibrosis cd34 cells in vitro proof of concept for combination therapy |
| url | http://journals.lww.com/10.1097/01.HS9.0000970916.77031.e7 |
| work_keys_str_mv | AT cirorinaldi p1003ruxolitinibandmagrolimabincreasescalreticulininmyelofibrosiscd34cellsinvitroproofofconceptforcombinationtherapy AT kristianboasman p1003ruxolitinibandmagrolimabincreasescalreticulininmyelofibrosiscd34cellsinvitroproofofconceptforcombinationtherapy AT matthewsimmonds p1003ruxolitinibandmagrolimabincreasescalreticulininmyelofibrosiscd34cellsinvitroproofofconceptforcombinationtherapy |